|
#16
28.08.2008, 14:35
|
||||
|
||||
|
[Ссылки доступны только зарегистрированным пользователям ]
не удержался, сорри за некоторый оффтоп))) эй ви тайп уан мобиц..  и еще [Ссылки доступны только зарегистрированным пользователям ] 
|
|
#18
13.09.2008, 07:14
|
||||
|
||||
|
Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure
[Ссылки доступны только зарегистрированным пользователям ]
|
|
#19
02.10.2008, 10:50
|
||||
|
||||
|
Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel.
[Ссылки доступны только зарегистрированным пользователям ] Cardiac Risk of Noncardiac Surgery after Percutaneous Coronary Intervention with Drug-eluting Stents. [Ссылки доступны только зарегистрированным пользователям ]
|
|
#20
06.10.2008, 12:59
|
||||
|
||||
|
1)A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease
[Ссылки доступны только зарегистрированным пользователям ] 2)Optimal Medical Therapy Is a Proven Option for Chronic Stable Angina [Ссылки доступны только зарегистрированным пользователям ] 3)PCI for Chronic Stable Angina [Ссылки доступны только зарегистрированным пользователям ] 4)Percutaneous Coronary Intervention for Stable Coronary Artery Disease [Ссылки доступны только зарегистрированным пользователям ]
|
|
#21
13.10.2008, 22:04
|
|||
|
|||
|
Kounis syndrome
[Ссылки доступны только зарегистрированным пользователям ]
International Journal of Cardiology, article in press Kounis syndrome: A manifestation of drug-eluting stent thrombosis associated with allergic reaction to contrast material John S. Kogias, Emmanouil X. Papadakis, Constantinos G. Tsatiris, George Hahalis,George N. Kounis, Andreas Mazarakis, Maria Batsolaki, Georgia V. Gouvelou-Deligianni, Nicholas G. Kounis Abstract Stent components acting as potential antigens and promoting intracoronary mast cell activation can lead to catastrophic intrastent thrombosis. Patients with drug-eluting stent (DES) implantation are prone to hypersensitivity reactions from five potential antigens namely, nickel strut, polymer coating, eluted drug, as well as, concomitant drugs clopidogrel and aspirin. These events may be more common than suspected because it is hard to document them, unless they become systemic, in which case they manifest themselves as the Kounis syndrome characterized by the concurrence of acute coronary events with hypersensitivity reactions. This report concerns of a patient with implanted DES who developed an acute myocardial infarction in the stent area following an allergic reaction to contrast material. © 2008 Elsevier Ireland Ltd. All rights reserved.
|
|
#22
28.10.2008, 00:37
|
|||
|
|||
|
ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay
[Ссылки доступны только зарегистрированным пользователям ]
|
|
|
|
#23
30.10.2008, 22:43
|
|||
|
|||
|
Aspirin and Clopidogrel Response Variability
Angela D. Ferguson, DO Hisham Dokainish, MD, FACC Nasser Lakkis, MD, FACC Antiplatelet resistance has been proposed as a possible mechanism to explain recurrent cardiovascular events in patients who have coronary artery disease and who are undergoing dual antiplatelet therapy. A comprehensive search on PubMed was conducted for literature that was printed in the English language between January 1996 and November 2007 on aspirin and clopidogrel resistance. Significant traits for aspirin hyporesponsiveness were female sex, older age, and lower levels of hemoglobin. Diabetes mellitus and elevated body mass index showed trends toward a higher incidence of resistance in someaspirin trials but did not reach statistical significance. Clopidogrel studies suggested that patients with type-2 diabetes mellitus are more likely to manifest inadequate response to the medication. Although 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors were initially suspected to decrease response to clopidogrel, later studies refuted this possibility. Patients with a suboptimal response to aspirin or clopidogrel seem to be at increased risk of recurrent cardiovascular events. Large clinical trials with standardized laboratory methods and well-defined protocols are needed to determine whether common features exist in patients with suspected hyporesponsiveness to antiplatelet therapy, and to validate the clinical relevance of response variability. A concise nonarbitrary definition of physiologic “resistance” is needed, and investigators should identify patients as having a variable response to antiplatelet therapy. (Tex Heart Inst J 2008;35(3):313-20) [Ссылки доступны только зарегистрированным пользователям ] А это просто любопытно SHOSHIN BERIBERI MIMICKING A HIGH-RISK NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME WITH CARDIOGENIC SHOCK: WHEN THE ARTERIES ARE NOT GUILTY [Ссылки доступны только зарегистрированным пользователям ]
|
|
#24
01.11.2008, 10:41
|
|||
|
|||
|
Здравствуйте, уважаемые коллеги!!!
 Очень хочется прочитать full text статьи:«J Am Coll Cardiol Intv, 2008; 1:351-357, doi:10.1016/j.jcin.2008.06.003 The "Crush" Technique for Coronary Artery Bifurcation Stenting: Insights From Micro-Computed Tomographic Imaging of Bench Deployments» Если есть возможность, выложите в общий доступ. Премного благодарен!
|
|
#25
01.11.2008, 17:18
|
||||
|
||||
|
По-моему, актуально.
Duration of antiplatelet therapy following intracoronary stenting: are changes needed? [Ссылки доступны только зарегистрированным пользователям ]
|
?|
#30
04.11.2008, 22:41
|
||||
|
||||
|
Цитата:
|
Линейный вид
